ArticleCommunications chemistry2025

A Hybrid compound H93 treats prostate cancer by directly binding UHRF1 and promoting protein dimerization.

Yuxin Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.